Paxlovid will be available for those most at risk of developing a serious COVID-19 illness. Officially known as PF-07321332+ritonavir, it is the second antiviral pill to be made available to thousands of people with weakened immune systems. It will be rolled out from February 10.
The drug, made by US pharmaceutical giant Pfizer, can reportedly slash the risk of hospital admission or death by up to 88 percent if it is administered within the first five days of symptoms, clinical studies have shown.
This may prove vital for “high risk” individuals with weakned immune systems.
This is a breaking story. More to follow.